NCT07058337View on ClinicalTrials.gov

Methotrexate in Retinal Detachment With Proliferative Vitreoretinopathy

NACompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

June 9, 2024

Primary Completion Date

June 1, 2025

Study Completion Date

June 9, 2025

Conditions
Retinal Detachment
Interventions
PROCEDURE

parsplana vitrectomy

23 gauge parsplana vitrectomy

PROCEDURE

adjunctive use of Methotrexate

intravitreal methotrexate (200 μg/0.05 ml) at the time of surgery and repeated weekly for four weeks postoperatively

Trial Locations (1)

4450113

Ebsar Eye Center, Cairo

All Listed Sponsors
lead

Benha University

OTHER

NCT07058337 - Methotrexate in Retinal Detachment With Proliferative Vitreoretinopathy | Biotech Hunter | Biotech Hunter